3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
UNKNOWN
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Hepatocellular
57
Stomach Neoplasms
45
Carcinoma, Non-Small-Cell Lung
36
Colorectal Neoplasms
24
Esophageal Squamous Cell Carcinoma
19
Rectal Neoplasms
11
Lung Neoplasms
11
Esophageal Neoplasms
11
Nasopharyngeal Carcinoma
10
Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
7
Pancreatic Neoplasms
7
Neoplasm Metastasis
7
Cholangiocarcinoma
6
Uterine Cervical Neoplasms
5
Small Cell Lung Carcinoma
5
Triple Negative Breast Neoplasms
4
Recurrence
4
Liver Neoplasms
4
Endometrial Neoplasms
4
Colonic Neoplasms
4
Carcinoma, Renal Cell
4
Solid Tumor
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Extranodal NK-T-Cell
3
Colorectal Cancer Metastatic
3
Carcinoma
3
Breast Neoplasms
3
Advanced Solid Tumors
3
Advanced Solid Tumor
3
Interventions
Cetuximab
2
Alpelisib
2
toripalimab
1
sintilimab
1
rocakinogene sifuplasmid
1
raltitrexed
1
cabozantinib
1
VGX-3100
1
Radiotherapy, Intensity-Modulated
1
Metformin
1
MEDI0457
1
Fluorouracil
1
Cisplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Head and Neck Squamous Cell Cancer
×
sintilimab
×
Clear all
NCT03975270
2019-07-18
HNSCC
ChineseAMS
Phase 2
Unknown
41 enrolled